SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-12-001614
Filing Date
2012-02-27
Accepted
2012-02-27 16:23:46
Documents
16
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2207068z10-k.htm 10-K 1156976
2 EX-10.3 a2207068zex-10_3.htm EX-10.3 1004699
3 EX-10.24 a2207068zex-10_24.htm EX-10.24 290456
4 EX-10.34 a2207068zex-10_34.htm EX-10.34 135842
5 EX-23.1 a2207068zex-23_1.htm EX-23.1 3333
6 EX-31.1 a2207068zex-31_1.htm EX-31.1 8054
7 EX-31.2 a2207068zex-31_2.htm EX-31.2 8066
8 EX-32 a2207068zex-32.htm EX-32 8789
15 G926522.JPG g926522.jpg GRAPHIC 85324
16 G905648.JPG g905648.jpg GRAPHIC 55476
  Complete submission text file 0001047469-12-001614.txt   10315051

Data Files

Seq Description Document Type Size
9 EX-101.INS thrx-20111231.xml EX-101.INS 1178414
10 EX-101.SCH thrx-20111231.xsd EX-101.SCH 64880
11 EX-101.CAL thrx-20111231_cal.xml EX-101.CAL 79530
12 EX-101.LAB thrx-20111231_lab.xml EX-101.LAB 1165116
13 EX-101.PRE thrx-20111231_pre.xml EX-101.PRE 542881
14 EX-101.DEF thrx-20111231_def.xml EX-101.DEF 410263
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30319 | Film No.: 12642250
SIC: 2834 Pharmaceutical Preparations